Sector Update: Health Care Stocks Decline Thursday Afternoon
JPMorgan Chase Reduces Stake in Hims & Hers Health to 1.7%
Most and Least Shorted Stocks Over $2B Market Cap
Hims & Hers Health Options Spot-On: On March 4th, 103.87K Contracts Were Traded, With 1.02 Million Open Interest
On March 4th ET, $Hims & Hers Health(HIMS.US)$ had active options trading, with a total trading volume of 103.87K options for the day, of which put options accounted for 29.28% of the total
Hims & Hers Slips as FDA Targets GLP-1 Compounders
Most and Least Shorted Mid-to Mega-cap Healthcare Stocks in February
Hims & Hers Health's Options Frenzy: What You Need to Know
EXCLUSIVE: Top 12 Most-Searched Tickers On Benzinga Pro In February — Where Do Tesla, Nvidia, Palantir Stocks Rank?
Hims' Partner Strive Reportedly Planning to Launch Copies of Novo's Wegovy Pill
Can Hims & Hers Overcome the FDA's GLP-1 Crackdown?
Morgan Stanley Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $21
Hims & Hers: Oversold Shares With Strong Platform but Regulated Headwinds Support a Balanced Hold Rating
Hims & Hers Stock (HIMS) Surged 13.5% — Could More Gains Be Ahead?
Hims & Hers Health Options Spot-On: On March 2nd, 170.48K Contracts Were Traded, With 1.17 Million Open Interest
On March 2nd ET, $Hims & Hers Health(HIMS.US)$ had active options trading, with a total trading volume of 170.48K options for the day, of which put options accounted for 22.57% of the total
Why Hims & Hers Health (HIMS) Is Down 6.4% After New Shelf Filing And Regulatory Scrutiny
What's Behind The Jump In Hims & Hers Health Stock?
Hims And Hers Health Weighs Regulatory Pressure Against Growth And Valuation
Analysis-Hims Expansion May Not Come in Time for Risky GLP-1 Business
Trending Stocks This Week as Wall Street Ends Lower on Nvidia Results, Hot PPI Data
Hims & Hers Expands Digital Health and Global Platform Strategy